Thursday, June 30, 2016

BRIEF-Medistim's technology has achieved reimbursement in Japan

* Valid from April 1, 2016, Ministry of Health, Labour and Welfare in Japan approved a

reimbursement of YEN 25,000 [EUR 225] when blood flow of the graft is controlled, using either

transit time flow measurement or high-resolution epicardial ultrasonography intraoperatively

Read more

No comments:

Post a Comment